Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hearing Loss × ebselen × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Hearing Loss 1

Interventions

sodium thiosulfate 2 ebselen 1 Sodium Chloride 1 Saline Solution 1 Ringer's Lactate 1 Platinum 1 Ofloxacin 1 Magnetic Resonance Spectroscopy 1 Hyaluronic Acid 1 Hearing 1 Cisplatin 1 Acetylcysteine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01452607 2016-06-29

Study to Evaluate the Safety and Pharmacokinetics of SPI-1005

Sound Pharmaceuticals, Incorporated

Phase 1 Completed

Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡